<SEC-DOCUMENT>0001104659-26-102795-index.html : 20260828
<SEC-HEADER>0001104659-26-102795.hdr.sgml : 20260828
<ACCEPTANCE-DATETIME>20260828083017
ACCESSION NUMBER: 0001104659-26-102795
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 14
CONFORMED PERIOD OF REPORT: 20260828
ITEM INFORMATION: Other Events
ITEM INFORMATION: Financial Statements and Exhibits
FILED AS OF DATE: 20260828
DATE AS OF CHANGE: 20260828

FILER:

 COMPANY DATA: 
 COMPANY CONFORMED NAME: Aprea Therapeutics, Inc.
 CENTRAL INDEX KEY: 0001781983
 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
 ORGANIZATION NAME: 03 Life Sciences
 EIN: 000000000
 STATE OF INCORPORATION: DE
 FISCAL YEAR END: 1231

 FILING VALUES:
 FORM TYPE: 8-K
 SEC ACT: 1934 Act
 SEC FILE NUMBER: 001-39069
 FILM NUMBER: 261333063

 BUSINESS ADDRESS: 
 STREET 1: 3805 OLD EASTON ROAD
 CITY: DOYLESTOWN
 STATE: PA
 ZIP: 18902
 BUSINESS PHONE: 215-948-4119

 MAIL ADDRESS: 
 STREET 1: 3805 OLD EASTON ROAD
 CITY: DOYLESTOWN
 STATE: PA
 ZIP: 18902
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>apre-20260828x8k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: apre-20260828x8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>apre-20260828xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
Document 2 - file: apre-20260828xex99d1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>apre-20260828xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: apre-20260828xex99d1001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>apre-20260828.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
Document 4 - file: apre-20260828.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>apre-20260828_def.xml
<DESCRIPTION>EX-101.DEF
<TEXT>
Document 5 - file: apre-20260828_def.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>apre-20260828_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
Document 6 - file: apre-20260828_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>apre-20260828_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
Document 7 - file: apre-20260828_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 9 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 10 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 11 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: FilingSummary.html

Document 13 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-26-102795-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 16 - file: 0001104659-26-102795-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>apre-20260828x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 17 - file: apre-20260828x8k_htm.html

Document 17 - RAW XML: apre-20260828x8k_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>